Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
DCPH was delisted on the 10th of June, 2024.
157 hedge funds and large institutions have $720M invested in Deciphera Pharmaceuticals, Inc. Common Stock in 2023 Q3 according to their latest regulatory filings, with 26 funds opening new positions, 49 increasing their positions, 55 reducing their positions, and 14 closing their positions.
600% more call options, than puts
Call options by funds: $77K | Put options by funds: $11K
86% more first-time investments, than exits
New positions opened: 26 | Existing positions closed: 14
8% more funds holding
Funds holding: 145 → 157 (+12)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
9% less capital invested
Capital invested by funds: $792M → $720M (-$72.5M)
11% less repeat investments, than reductions
Existing positions increased: 49 | Existing positions reduced: 55
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
EC
EcoR1 Capital
San Francisco,
California
|
+$13.7M |
| 2 |
GTC
Ghost Tree Capital
New York
|
+$4.48M |
| 3 |
JFG
Jefferies Financial Group
New York
|
+$4.26M |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$3.24M |
| 5 |
Morgan Stanley
New York
|
+$3.07M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
State Street
Boston,
Massachusetts
|
-$11.8M |
| 2 |
RG
Redmile Group
San Francisco,
California
|
-$5.56M |
| 3 |
B
Braidwell
Stamford,
Connecticut
|
-$4.28M |
| 4 |
ECM
ExodusPoint Capital Management
New York
|
-$2.82M |
| 5 |
IC
Ikarian Capital
Dallas,
Texas
|
-$2.46M |
DCPH Hedge Fund Activity: Q3 2023 in Review
157 of the 6,301 institutional investors tracked by Wall St. Rank reported a position in Deciphera Pharmaceuticals, Inc. Common Stock (DCPH) for Q3 2023, worth a combined $720M — down 9.1% from $792M a quarter earlier.
Buyers outnumbered sellers: 26 funds opened new DCPH positions and 14 closed out — a net gain of 12 holders — while 49 added to existing stakes and 55 trimmed.
The largest buyer was EcoR1 Capital, opening a new position worth an estimated $13.7M. The largest seller was State Street, cutting an estimated $11.8M.
- 157 institutional investors held Deciphera Pharmaceuticals, Inc. Common Stock (DCPH) as of Q3 2023, up from 145 in Q2 2023.
- Funds reported $720M of Deciphera Pharmaceuticals, Inc. Common Stock stock for Q3 2023, down 9.1% quarter-over-quarter.
- 26 funds opened new Deciphera Pharmaceuticals, Inc. Common Stock positions in Q3 2023 and 14 closed out, a net change of +12 holders.
- The largest Deciphera Pharmaceuticals, Inc. Common Stock buyer in Q3 2023 was EcoR1 Capital, an estimated $13.7M added.
- The largest Deciphera Pharmaceuticals, Inc. Common Stock seller in Q3 2023 was State Street, an estimated $11.8M sold.
Based on aggregated 13F filings for Q3 2023.